Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myriad Genetics Inc (MYGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myriad Genetics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 899923.
Total stock buying since 2005: $951,678.
Total stock sales since 2005: $299,133,778.
Total stock option exercises since 2005: $124,356,444.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 339,094 | $8,717,764 | 0 | $0 |
| 2023 | 0 | $0 | 75,671 | $1,405,272 | 0 | $0 |
| 2022 | 0 | $0 | 26,424 | $426,674 | 0 | $0 |
| 2021 | 0 | $0 | 782,929 | $25,835,272 | 748,188 | $18,223,254 |
| 2020 | 15,000 | $249,330 | 14,431 | $342,733 | 0 | $0 |
| 2019 | 12,860 | $314,218 | 235,687 | $10,177,500 | 198,307 | $5,080,990 |
| 2018 | 0 | $0 | 695,789 | $27,855,954 | 685,805 | $18,069,907 |
| 2017 | 6,000 | $111,922 | 46,531 | $1,454,851 | 30,000 | $493,800 |
| 2016 | 11,000 | $233,889 | 78,637 | $2,347,407 | 80,619 | $1,219,367 |
| 2015 | 0 | $0 | 370,999 | $15,320,891 | 378,317 | $7,948,988 |
| 2014 | 0 | $0 | 1,448,950 | $53,054,636 | 1,451,407 | $26,892,939 |
| 2013 | 0 | $0 | 320,505 | $10,320,336 | 320,505 | $4,027,236 |
| 2012 | 0 | $0 | 1,249,711 | $34,019,684 | 1,259,196 | $11,387,218 |
| 2011 | 0 | $0 | 213,614 | $5,120,688 | 214,422 | $2,716,958 |
| 2010 | 0 | $0 | 205,976 | $4,710,100 | 169,866 | $1,462,794 |
| 2009 | 1,300 | $42,319 | 570,759 | $25,284,784 | 564,063 | $7,308,282 |
| 2008 | 0 | $0 | 398,433 | $23,861,221 | 505,598 | $6,771,508 |
| 2007 | 0 | $0 | 881,185 | $40,235,657 | 770,771 | $9,640,404 |
| 2006 | 0 | $0 | 324,336 | $8,593,443 | 286,134 | $3,112,799 |
| 2005 | 0 | $0 | 2,448 | $48,911 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-09-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 18,658 | 50.00 | 932,900 |
| 2007-09-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 18,658 | 4.78 | 89,203 |
| 2007-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 20,000 | 50.00 | 1,000,000 |
| 2007-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 20,000 | 5.12 | 102,500 |
| 2007-09-14 | Meldrum Peter D (President & C.E.O.) | Sale | 11,262 | 47.07 | 530,124 |
| 2007-09-14 | Meldrum Peter D (President & C.E.O.) | Option Ex | 11,262 | 9.31 | 104,871 |
| 2007-09-13 | Evans James S (V.P. Finance) | Sale | 3,914 | 47.20 | 184,729 |
| 2007-09-13 | Moyes Jay M (Chief Financial Officer) | Sale | 59,881 | 47.28 | 2,833,441 |
| 2007-09-13 | Moyes Jay M (Chief Financial Officer) | Option Ex | 59,881 | 8.94 | 526,266 |
| 2007-09-12 | Moyes Jay M (Chief Financial Officer) | Sale | 20,397 | 47.16 | 962,004 |
| 2007-09-12 | Moyes Jay M (Chief Financial Officer) | Option Ex | 20,397 | 6.46 | 131,683 |
| 2007-09-12 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 47.22 | 472,150 |
| 2007-09-12 | Meldrum Peter D (President & C.E.O.) | Option Ex | 10,000 | 9.31 | 93,120 |
| 2007-08-09 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 47.01 | 470,070 |
| 2007-08-09 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 10,000 | 14.81 | 148,100 |
| 2007-08-07 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 4,773 | 43.03 | 205,406 |
| 2007-08-07 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 4,773 | 15.28 | 72,931 |
| 2007-08-07 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 9,000 | 40.25 | 362,250 |
| 2007-08-07 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 9,000 | 19.50 | 175,500 |
| 2007-08-07 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 15,000 | 42.10 | 631,545 |
| 2007-08-07 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 15,000 | 14.81 | 222,150 |
| 2007-08-06 | Marsh Richard M (V.P., General Counsel) | Sale | 579 | 40.00 | 23,160 |
| 2007-07-16 | Marsh Richard M (V.P., General Counsel) | Sale | 5,581 | 40.00 | 223,240 |
| 2007-06-18 | Marsh Richard M (V.P., General Counsel) | Sale | 6,000 | 37.81 | 226,860 |
| 2007-06-15 | Moyes Jay M (Chief Financial Officer) | Sale | 1,500 | 37.73 | 56,594 |
| 2007-06-07 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 20,000 | 13.56 | 271,240 |
| 2007-05-31 | Skolnick Mark H (Chief Scientific Officer) | Sale | 30,000 | 38.29 | 1,148,610 |
| 2007-05-31 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 30,000 | 13.56 | 406,860 |
| 2007-05-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 10,000 | 40.00 | 400,000 |
| 2007-05-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 10,000 | 5.12 | 51,250 |
| 2007-05-09 | Gilbert Walter Phd (Director) | Sale | 30,000 | 38.05 | 1,141,590 |
| 2007-05-09 | Gilbert Walter Phd (Director) | Option Ex | 30,000 | 10.70 | 321,090 |
| 2007-05-08 | Skolnick Mark H (Chief Scientific Officer) | Sale | 30,000 | 38.06 | 1,141,770 |
| 2007-05-08 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 30,000 | 13.56 | 406,860 |
| 2007-05-04 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 39.38 | 787,680 |
| 2007-05-03 | Hayes Arthur Hull Jr (Director) | Sale | 15,000 | 39.71 | 595,710 |
| 2007-05-03 | Hayes Arthur Hull Jr (Director) | Option Ex | 15,000 | 13.00 | 195,000 |
| 2007-05-03 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 84,151 | 39.74 | 3,344,413 |
| 2007-05-03 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 84,151 | 17.07 | 1,436,205 |
| 2007-05-02 | Meldrum Peter D (President & C.E.O.) | Sale | 9,400 | 38.00 | 357,200 |
| 2007-05-01 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 8,750 | 37.00 | 323,750 |
| 2007-05-01 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 8,750 | 12.54 | 109,724 |
| 2007-05-01 | Marsh Richard M (V.P., General Counsel) | Sale | 3,991 | 37.50 | 149,662 |
| 2007-05-01 | Meldrum Peter D (President & C.E.O.) | Sale | 600 | 38.00 | 22,800 |
| 2007-04-16 | Marsh Richard M (V.P., General Counsel) | Sale | 5,000 | 36.08 | 180,385 |
| 2007-03-23 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 5,400 | 14.75 | 79,650 |
| 2007-03-13 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 16,725 | 33.28 | 556,541 |
| 2007-03-13 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 16,725 | 11.64 | 194,679 |
| 2007-03-12 | Skolnick Mark H (Chief Scientific Officer) | Sale | 5,000 | 33.81 | 169,050 |
| 2007-03-07 | Wilson Linda S (Director) | Option Ex | 2,500 | 10.19 | 25,467 |
| 2007-02-06 | Evans James S (Vice President Finance) | Sale | 5,626 | 37.00 | 208,162 |
| 2007-02-06 | Evans James S (Vice President Finance) | Option Ex | 5,626 | 5.12 | 28,833 |
| 2007-01-16 | Simon S George (V.P. Business Development) | Sale | 5,000 | 35.09 | 175,435 |
| 2007-01-16 | Simon S George (V.P. Business Development) | Option Ex | 5,000 | 12.54 | 62,699 |
| 2007-01-12 | Simon S George (V.P. Business Development) | Sale | 5,000 | 35.00 | 175,015 |
| 2007-01-12 | Simon S George (V.P. Business Development) | Option Ex | 5,000 | 11.64 | 58,200 |
| 2007-01-12 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 35.00 | 350,000 |
| 2007-01-11 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 5,000 | 34.00 | 170,000 |
| 2007-01-11 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 5,000 | 12.54 | 62,699 |
| 2007-01-10 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 33.00 | 330,000 |
| 2007-01-09 | Moyes Jay M (Chief Financial Officer) | Sale | 8,156 | 32.50 | 265,070 |
| 2007-01-09 | Moyes Jay M (Chief Financial Officer) | Option Ex | 8,156 | 13.56 | 110,611 |
| 2007-01-03 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 5,000 | 32.00 | 160,000 |
| 2007-01-03 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-01-03 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 5,000 | 32.00 | 160,000 |
| 2007-01-03 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 5,000 | 4.78 | 23,905 |
| 2006-12-13 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 30.90 | 618,000 |
| 2006-11-20 | Moyes Jay M (Chief Financial Officer) | Sale | 4,800 | 30.00 | 144,000 |
| 2006-11-20 | Moyes Jay M (Chief Financial Officer) | Option Ex | 4,800 | 13.56 | 65,097 |
| 2006-11-17 | Moyes Jay M (Chief Financial Officer) | Sale | 333 | 30.00 | 9,990 |
| 2006-11-17 | Moyes Jay M (Chief Financial Officer) | Option Ex | 333 | 13.56 | 4,516 |
| 2006-11-16 | Moyes Jay M (Chief Financial Officer) | Sale | 3,023 | 30.00 | 90,690 |
| 2006-11-16 | Moyes Jay M (Chief Financial Officer) | Option Ex | 3,023 | 13.56 | 40,997 |
| 2006-11-15 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 4,176 | 29.00 | 121,104 |
| 2006-11-15 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 4,176 | 12.54 | 52,367 |
| 2006-11-10 | Gilbert Walter Phd (Director) | Sale | 26,297 | 26.93 | 708,151 |
| 2006-11-09 | Gilbert Walter Phd (Director) | Sale | 9,643 | 27.14 | 261,672 |
| 2006-11-07 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 824 | 29.00 | 23,896 |
| 2006-11-07 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 824 | 12.54 | 10,332 |
| 2006-10-19 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 8,588 | 28.00 | 240,464 |
| 2006-10-19 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 8,588 | 5.01 | 43,025 |
| 2006-10-18 | Moyes Jay M (Chief Financial Officer) | Sale | 5,000 | 27.08 | 135,395 |
| 2006-08-30 | Hayes Arthur Hull Jr (Director) | Sale | 15,000 | 25.13 | 376,935 |
| 2006-08-30 | Hayes Arthur Hull Jr (Director) | Option Ex | 15,000 | 14.12 | 211,875 |
| 2006-06-13 | Moyes Jay M (Chief Financial Officer) | Option Ex | 15,444 | 12.38 | 191,119 |
| 2006-06-07 | Skolnick Mark H (Chief Scientific Officer) | Sale | 27,000 | 24.93 | 673,083 |
| 2006-06-07 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 27,000 | 12.38 | 334,125 |
| 2006-05-08 | Skolnick Mark H (Chief Scientific Officer) | Sale | 21,436 | 28.00 | 600,208 |
| 2006-05-08 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 21,436 | 12.38 | 265,270 |
| 2006-05-05 | Simon S George (V.P. Business Development) | Sale | 10,000 | 28.02 | 280,160 |
| 2006-05-05 | Simon S George (V.P. Business Development) | Option Ex | 10,000 | 10.74 | 107,400 |
| 2006-05-04 | Meldrum Peter D (President & C.E.O.) | Sale | 8,628 | 28.00 | 241,584 |
| 2006-05-04 | Meldrum Peter D (President & C.E.O.) | Option Ex | 8,628 | 13.56 | 117,012 |
| 2006-04-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 35,556 | 24.55 | 872,935 |
| 2006-04-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 35,556 | 7.03 | 249,994 |
| 2006-03-23 | Evans James S (V.P. Finance) | Option Ex | 1,500 | 5.12 | 7,687 |
| 2006-03-23 | Meldrum Peter D (President & C.E.O.) | Option Ex | 9,230 | 11.64 | 107,437 |
| 2006-03-13 | Marsh Richard M (V.P., General Counsel) | Sale | 10,000 | 27.55 | 275,520 |
| 2006-03-13 | Marsh Richard M (V.P., General Counsel) | Option Ex | 10,000 | 12.54 | 125,399 |
| 2006-03-10 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 16,564 | 12.38 | 204,979 |
| 2006-03-09 | Gilbert Walter Phd (Director) | Sale | 6,300 | 26.00 | 163,800 |
| 2006-03-09 | Gilbert Walter Phd (Director) | Option Ex | 6,300 | 13.00 | 81,900 |
| 2006-03-08 | Hayes Arthur Hull Jr (Director) | Sale | 25,000 | 25.74 | 643,575 |
| 2006-03-08 | Hayes Arthur Hull Jr (Director) | Option Ex | 15,000 | 5.69 | 85,305 |
| 2006-03-08 | Gilbert Walter Phd (Director) | Sale | 36,600 | 25.85 | 946,219 |
| 2006-03-08 | Gilbert Walter Phd (Director) | Option Ex | 36,600 | 10.19 | 372,844 |
| 2006-03-07 | Gilbert Walter Phd (Director) | Sale | 12,100 | 25.97 | 314,249 |
| 2006-03-07 | Gilbert Walter Phd (Director) | Option Ex | 12,100 | 14.12 | 170,912 |
| 2006-02-27 | Moyes Jay M (Chief Financial Officer) | Sale | 2,900 | 25.21 | 73,100 |
| 2006-02-27 | Moyes Jay M (Chief Financial Officer) | Option Ex | 2,900 | 12.38 | 35,887 |
| 2006-02-13 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 25.00 | 250,000 |
| 2006-02-10 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 3,588 | 25.00 | 89,700 |
| 2006-02-10 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 3,588 | 5.12 | 18,388 |
| 2006-02-10 | Simon S George (V.P. Business Development) | Sale | 5,000 | 25.00 | 125,000 |
| 2006-02-10 | Simon S George (V.P. Business Development) | Option Ex | 5,000 | 10.74 | 53,700 |
| 2006-02-10 | Moyes Jay M (Chief Financial Officer) | Sale | 12,544 | 25.03 | 314,013 |
| 2006-02-10 | Moyes Jay M (Chief Financial Officer) | Option Ex | 12,544 | 12.38 | 155,232 |
| 2005-12-21 | Moyes Jay M (Chief Financial Officer) | Sale | 2,448 | 19.98 | 48,911 |
Insider trading activities including stock purchases, stock sales, and option exercises of MYGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myriad Genetics Inc (symbol MYGN, CIK number 899923) see the Securities and Exchange Commission (SEC) website.